title: Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
abstract: Kaposi's sarcoma-associated herpesvirus (KSHV), the etiologic agent of Kaposi's sarcoma (KS), is present in the predominant tumor cells of KS, the spindle cells. Spindle cells express markers of lymphatic endothelium and, interestingly, KSHV infection of blood endothelial cells reprograms them to a lymphatic endothelial cell phenotype. KSHV-induced reprogramming requires the activation of STAT3 and phosphatidylinositol 3 (PI3)/AKT through the activation of cellular receptor gp130. Importantly, KSHV-induced reprogramming is specific to endothelial cells, indicating that there are additional host genes that are differentially regulated during KSHV infection of endothelial cells that contribute to lymphatic reprogramming. We found that the transcription factor Ets-1 is highly expressed in KS spindle cells and is upregulated during KSHV infection of endothelial cells in culture. The KSHV latent vFLIP gene is sufficient to induce Ets-1 expression in an NF-κB-dependent fashion. Ets-1 is required for KSHV-induced expression of VEGFR3, a lymphatic endothelial-cell-specific receptor important for lymphangiogenesis, and Ets-1 activates the promoter of VEGFR3. Ets-1 knockdown does not alter the expression of another lymphatic-specific gene, the podoplanin gene, but does inhibit the expression of VEGFR3 in uninfected lymphatic endothelium, indicating that Ets-1 is a novel cellular regulator of VEGFR3 expression. Knockdown of Ets-1 affects the ability of KSHV-infected cells to display angiogenic phenotypes, indicating that Ets-1 plays a role in KSHV activation of endothelial cells during latent KSHV infection. Thus, Ets-1 is a novel regulator of VEGFR3 and is involved in the induction of angiogenic phenotypes by KSHV.
authors.affiliation: Department of Microbiology, University of Washington, Seattle, Washington, USA.
authors.forename: Kimberley D
authors.initials: KD
authors.lastname: Gutierrez
authors.forename: Valerie A
authors.initials: VA
authors.lastname: Morris
authors.forename: David
authors.initials: D
authors.lastname: Wu
authors.forename: Serge
authors.initials: S
authors.lastname: Barcy
authors.forename: Michael
authors.initials: M
authors.lastname: Lagunoff
mesh_terms: D002460:Cell Line; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000378:metabolism / Q000473:pathology* / Q000821:virology*; D005786:Gene Expression Regulation; D006566:Herpesviridae Infections / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D019288:Herpesvirus 8, Human / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D042601:Lymphatic Vessels / Q000166:cytology / Q000821:virology; D011401:Promoter Regions, Genetic; D050784:Proto-Oncogene Protein c-ets-1 / Q000235:genetics / Q000378:metabolism*; D012514:Sarcoma, Kaposi / Q000821:virology*; D015854:Up-Regulation; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000235:genetics / Q000378:metabolism*; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism; D017735:Virus Latency
chemical_list: C494041:ETS1 protein, human; D050784:Proto-Oncogene Protein c-ets-1; D014764:Viral Proteins; C581309:FLT4 protein, human; D040321:Vascular Endothelial Growth Factor Receptor-3
references.citation: PLoS Pathog. 2011 Dec;7(12):e1002424
references.pmid: 22174684
references.citation: J Virol. 2007 Apr;81(8):3980-91
references.pmid: 17287278
references.citation: J Cell Physiol. 2008 Dec;217(3):809-18
references.pmid: 18720385
references.citation: Oncogene. 1999 Oct 14;18(42):5738-46
references.pmid: 10523854
references.citation: Blood. 2011 Sep 8;118(10):2896-905
references.pmid: 21715310
references.citation: New Biol. 1992 May;4(5):512-9
references.pmid: 1515415
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5570-5
references.pmid: 15800047
references.citation: Int J Oncol. 2011 Jun;38(6):1645-52
references.pmid: 21424123
references.citation: Cancer Res. 1998 Dec 1;58(23):5321-5
references.pmid: 9850057
references.citation: Cancer. 2000 Oct 15;89(8):1670-6
references.pmid: 11042559
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7170-5
references.pmid: 9207063
references.citation: Mol Cell Biol. 1999 Apr;19(4):2946-57
references.pmid: 10082562
references.citation: Epidemiol Rev. 1991;13:178-99
references.pmid: 1765111
references.citation: Cancer Sci. 2004 Aug;95(8):626-33
references.pmid: 15298723
references.citation: J Biol Chem. 1996 Nov 29;271(48):30823-8
references.pmid: 8940064
references.citation: N Engl J Med. 2000 Apr 6;342(14):1027-38
references.pmid: 10749966
references.citation: Acta Virol. 2011;55(2):161-4
references.pmid: 21692565
references.citation: J Virol. 1999 Jul;73(7):5722-30
references.pmid: 10364323
references.citation: Biochem Biophys Res Commun. 2009 Jan 9;378(2):213-7
references.pmid: 19022222
references.citation: Virology. 2004 Oct 10;328(1):7-18
references.pmid: 15380353
references.citation: J Biol Chem. 2006 Sep 22;281(38):28113-21
references.pmid: 16861237
references.citation: J Virol. 1997 Jan;71(1):715-9
references.pmid: 8985403
references.citation: Cancer Res. 2007 May 1;67(9):4042-51
references.pmid: 17483315
references.citation: J Biomed Sci. 2003 May-Jun;10(3):320-7
references.pmid: 12711859
references.citation: Cell Struct Funct. 2001 Feb;26(1):19-24
references.pmid: 11345500
references.citation: Am J Pathol. 1993 Jul;143(1):240-9
references.pmid: 8100400
references.citation: Annu Rev Cell Dev Biol. 2005;21:457-83
references.pmid: 16212503
references.citation: Am J Pathol. 2001 Jul;159(1):27-33
references.pmid: 11438450
references.citation: J Cell Sci. 2011 Aug 15;124(Pt 16):2753-62
references.pmid: 21807940
references.citation: Semin Immunol. 2002 Dec;14(6):453-60
references.pmid: 12457618
references.citation: Mol Cancer. 2003 Aug 20;2:29
references.pmid: 12971829
references.citation: Mod Pathol. 2001 May;14(5):415-22
references.pmid: 11353051
references.citation: J Virol. 2008 Sep;82(17):8771-9
references.pmid: 18579585
references.citation: J Virol. 2010 Jun;84(11):5565-73
references.pmid: 20219929
references.citation: J Virol. 2002 Mar;76(5):2440-8
references.pmid: 11836422
references.citation: Mol Cell Biol. 1998 Apr;18(4):2218-29
references.pmid: 9528793
references.citation: J Virol. 1998 Oct;72(10):8309-15
references.pmid: 9733875
references.citation: Annu Rev Pathol. 2006;1:273-96
references.pmid: 18039116
references.citation: Blood. 2005 Mar 15;105(6):2510-8
references.pmid: 15572586
references.citation: Blood. 2009 Jul 30;114(5):1123-30
references.pmid: 19411629
references.citation: Histol Histopathol. 2005 Jan;20(1):119-26
references.pmid: 15578430
references.citation: Mini Rev Med Chem. 2008 Oct;8(11):1095-105
references.pmid: 18855726
references.citation: Virology. 2008 Feb 5;371(1):139-54
references.pmid: 17964626
references.citation: Front Microbiol. 2012 Mar 30;3:102
references.pmid: 22479258
references.citation: Cytokine. 2010 Sep;51(3):217-26
references.pmid: 20378371
references.citation: Lab Invest. 1999 Feb;79(2):243-51
references.pmid: 10068212
references.citation: Virology. 2012 Jul 5;428(2):112-20
references.pmid: 22521915
references.citation: Int J Biochem Cell Biol. 2001 Apr;33(4):391-407
references.pmid: 11312108
references.citation: Oncology. 2004;66(5):420-8
references.pmid: 15331930
references.citation: Cancer Res. 2008 Jun 15;68(12):4640-8
references.pmid: 18559509
references.citation: J Biol Chem. 2008 Sep 12;283(37):25404-25413
references.pmid: 18625704
references.citation: Br J Cancer. 2004 Oct 4;91(7):1308-15
references.pmid: 15365563
references.citation: Nat Genet. 2004 Jul;36(7):683-5
references.pmid: 15220917
references.citation: J Invest Dermatol. 1999 Dec;113(6):1047-53
references.pmid: 10594750
references.citation: Cancer Res. 1998 Apr 15;58(8):1599-604
references.pmid: 9563467
references.citation: J Clin Invest. 1997 Nov 15;100(10):2606-10
references.pmid: 9366576
references.citation: Nat Genet. 2004 Jul;36(7):687-93
references.pmid: 15220918
references.citation: Am J Pathol. 1996 Dec;149(6):1931-9
references.pmid: 8952528
references.citation: Oncogene. 2000 Dec 18;19(55):6503-13
references.pmid: 11175366
references.citation: Ann N Y Acad Sci. 2002 Dec;979:159-65; discussion 188-96
references.pmid: 12543725
references.citation: J Virol. 2011 Oct;85(19):10375-88
references.pmid: 21795355
references.citation: PLoS Pathog. 2007 Mar;3(3):e44
references.pmid: 17397260
references.citation: Ann N Y Acad Sci. 2000 May;902:201-5; discussion 205-7
references.pmid: 10865839
references.citation: Hum Cell. 1998 Dec;11(4):207-14
references.pmid: 10363158
references.citation: Ann N Y Acad Sci. 2001 Dec;947:117-23
references.pmid: 11795259
references.citation: Blood. 2011 Nov 10;118(19):5344-54
references.pmid: 21881052